Lyumjev cartouches 100 units/mL

Lyumjev cartouches 100 units/mL is a medicine authorised by Swissmedic under authorisation number 67793. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 December 2020 and the authorisation is limited until 30 June 2027. ATC code A10AB04 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 67793
  • ATC A10AB04
  • Biotechnological medicines
Authorisation data
Authorisation number67793
NameLyumjev cartouches 100 units/mL
Full nameLyumjev cartouches 100 units/mL, solution injectable
Authorisation holderEli Lilly (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeA10AB04
First authorisation03 December 2020
Authorisation validity30 June 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Lyumjev cartouches 100 units/mL, solution injectableB03 December 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15 x 3mlA10AB0407.06.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Lyumjev cartouches 100 units/mL authorised in Switzerland?

Yes. Lyumjev cartouches 100 units/mL is authorised by Swissmedic under authorisation number 67793, data as of 01 September 2026. The authorisation is limited until 30 June 2027.

Which dispensing category does Lyumjev cartouches 100 units/mL have?

Lyumjev cartouches 100 units/mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Lyumjev cartouches 100 units/mL?

The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com